Research advances of nonalcoholic fatty liver cirrhosis
10.3760/cma.j.issn.1008-6706.2020.23.029
- VernacularTitle:非酒精性脂肪性肝硬化的研究进展
- Author:
Hongmei ZHU
1
;
Qian YANG
;
Qinying WANG
Author Information
1. 山西医科大学第一医院感染病科，太原 030001
- From:
Chinese Journal of Primary Medicine and Pharmacy
2020;27(23):2940-2944
- CountryChina
- Language:Chinese
-
Abstract:
With the increasing incidence of obesity and metabolic syndrome, non-alcoholic fatty liver disease(NAFLD) has become the most common chronic liver disease worldwide, and is one of the leading causes of cirrhosis.Cirrhosis can lead to a sharp deterioration of liver function in patients, and is closely related to patients’ mortality.Therefore, non-alcoholic fatty liver cirrhosis should be strengthened the emphasis on.This article reviews the prevalence, risk factors, clinical features, diagnosis and treatment of NAFLD cirrhosis in recent years.
